^Kulick R, Chaiseha Y, Kang S, Rozenboim I, El Halawani M (2005). “The relative importance of vasoactive intestinal peptide and peptide histidine isoleucine as physiological regulators of prolactin in the domestic turkey”. Gen Comp Endocrinol142 (3): 267-73. doi:10.1016/j.ygcen.2004.12.024. PMID15935152.
Fahrenkrug J (2002). “Gut/brain peptides in the genital tract: VIP and PACAP.”. Scand. J. Clin. Lab. Invest. Suppl.234: 35-9. PMID11713978.
Delgado M, Pozo D, Ganea D (2004). “The significance of vasoactive intestinal peptide in immunomodulation.”. Pharmacol. Rev.56 (2): 249-90. doi:10.1124/pr.56.2.7. PMID15169929.
Conconi MT, Spinazzi R, Nussdorfer GG (2006). “Endogenous ligands of PACAP/VIP receptors in the autocrine-paracrine regulation of the adrenal gland.”. Int. Rev. Cytol.249: 1-51. doi:10.1016/S0074-7696(06)49001-X. PMID16697281.
Hill JM (2007). “Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.”. Curr. Pharm. Des.13 (11): 1079-89. doi:10.2174/138161207780618975. PMID17430171.
Gonzalez-Rey E, Varela N, Chorny A, Delgado M (2007). “Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.”. Curr. Pharm. Des.13 (11): 1113-39. doi:10.2174/138161207780618966. PMID17430175.
“[Quaternary structure of rabbit skeletal muscle glycogen synthetase]”. Dokl. Akad. Nauk SSSR222 (4): 997-1000. (1975). PMID807467.
Kitamura K, Kangawa K, Kawamoto M, et al. (1992). “Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma.”. Biochem. Biophys. Res. Commun.185 (1): 134-41. doi:10.1016/S0006-291X(05)80966-0. PMID1318039.
Glowa JR, Panlilio LV, Brenneman DE, et al. (1992). “Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist.”. Brain Res.570 (1-2): 49-53. doi:10.1016/0006-8993(92)90562-N. PMID1617429.
Theriault Y, Boulanger Y, St-Pierre S (1991). “Structural determination of the vasoactive intestinal peptide by two-dimensional H-NMR spectroscopy.”. Biopolymers31 (4): 459-64. doi:10.1002/bip.360310411. PMID1863695.
Gozes I, Giladi E, Shani Y (1987). “Vasoactive intestinal peptide gene: putative mechanism of information storage at the RNA level.”. J. Neurochem.48 (4): 1136-41. doi:10.1111/j.1471-4159.1987.tb05638.x. PMID2434617.
Yamagami T, Ohsawa K, Nishizawa M, et al. (1988). “Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.”. Ann. N. Y. Acad. Sci.527: 87-102. PMID2839091.
Bodner M, Fridkin M, Gozes I (1985). “Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome.”. Proc. Natl. Acad. Sci. U.S.A.82 (11): 3548-51. doi:10.1073/pnas.82.11.3548. PMID2987932.
DeLamarter JF, Buell GN, Kawashima E, et al. (1985). “Vasoactive intestinal peptide: expression of the prohormone in bacterial cells.”. Peptides6 Suppl 1: 95-102. doi:10.1016/0196-9781(85)90016-6. PMID2995945.
Linder S, Barkhem T, Norberg A, et al. (1987). “Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.”. Proc. Natl. Acad. Sci. U.S.A.84 (2): 605-9. doi:10.1073/pnas.84.2.605. PMID3025882.
Gotoh E, Yamagami T, Yamamoto H, Okamoto H (1989). “Chromosomal assignment of human VIP/PHM-27 gene to 6q26----q27 region by spot blot hybridization and in situ hybridization.”. Biochem. Int.17 (3): 555-62. PMID3202886.
Yiangou Y, Di Marzo V, Spokes RA, et al. (1987). “Isolation, characterization, and pharmacological actions of peptide histidine valine 42, a novel prepro-vasoactive intestinal peptide-derived peptide.”. J. Biol. Chem.262 (29): 14010-3. PMID3654650.
Gozes I, Bodner M, Shani Y, Fridkin M (1986). “Structure and expression of the vasoactive intestinal peptide (VIP) gene in a human tumor.”. Peptides7 Suppl 1: 1-6. doi:10.1016/0196-9781(86)90156-7. PMID3748844.
Tsukada T, Horovitch SJ, Montminy MR, et al. (1985). “Structure of the human vasoactive intestinal polypeptide gene.”. DNA4 (4): 293-300. PMID3899557.
Heinz-Erian P, Dey RD, Flux M, Said SI (1985). “Deficient vasoactive intestinal peptide innervation in the sweat glands of cystic fibrosis patients.”. Science229 (4720): 1407-8. doi:10.1126/science.4035357. PMID4035357.
Bloom SR, Christofides ND, Delamarter J, et al. (1984). “Diarrhoea in vipoma patients associated with cosecretion of a second active peptide (peptide histidine isoleucine) explained by single coding gene.”. Lancet2 (8360): 1163-5. PMID6139527.